During the past decade, Peninsula Cancer Institute conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 29 clinical trials were completed, i.e. on average, 138.1% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 9 clinical trials were completed. i.e. 56.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Peninsula Cancer Institute" #1 sponsor was "SCRI Development Innovations, LLC" with 20 trials, followed by "National Cancer Institute (NCI)" with 14 trials sponsored, "SWOG Cancer Research Network" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored and "Bristol-Myers Squibb" with 4 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Peninsula Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "Genentech, Inc." with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "North Central Cancer Treatment Group" with 4 trials as a collaborator and "Novartis" with 4 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Peninsula Cancer Institute" are "Breast Cancer" (12 trials), "Invasive Breast Carcinoma" (5 trials), "Non-Small Cell Lung Cancer" (4 trials), "Anatomic Stage II Breast Cancer AJCC v8" (3 trials) and "Breast Adenocarcinoma" (3 trials). Many other conditions were trialed in "Peninsula Cancer Institute" in a lesser frequency.

Most popular intervention types in "Peninsula Cancer Institute" are "Drug" (63 trials), "Other" (24 trials), "Biological" (15 trials), "Radiation" (7 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (14 trials), "Paclitaxel" (13 trials), "Carboplatin" (12 trials), "Laboratory Biomarker Analysis" (11 trials) and "Bevacizumab" (10 trials). Other intervention names were less common.

The vast majority of trials in "Peninsula Cancer Institute" are 52 trials for "All" genders, 20 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Peninsula Cancer Institute". undefined are not yet recruiting, 12 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Peninsula Cancer Institute, 2 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Peninsula Cancer Institute, 4 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".